Beckley Psytech, a private company dedicated to addressing neurological and psychiatric disorders through psychedelic medicine, has appointed Andy Page as its Chief Operating Officer with immediate effect. Page brings over 25 years’ experience working within global pharmaceutical and medtech organisations in strategic and operation roles. He started his career at SmithKline Beecham before joining…


Previous articleThe Psychedelic Entourage Effect: Part 6 – The State of the Art
Next articleTryp Therapeutics to Present at the Stifel GMP Healthcare Conference